Hot Products Epiquin Micro Generic Name: hydroquinone Dosage Form: cream Overview Side Effects Dosage Professional Pregnancy More User Reviews Support Group Q & A Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Epiquin Micro EpiQum- Micro ts a patented. multi-phasic formulation containing 4 distinct phases - an oil phase. a water phase. and two methyl methacrylate/glycol dmethacrylate crosspolymer microparticulate phases resulting from the incorporation of two different MICROSPONG delivery systems within the formula. The formula contains 4% hydroquinone USP. apportioned in both the water phase (1.5%) and in one of the microparticulate phases (2.5%) of the formulation. It also includes retinol (vitamin A), which is shown to penetrate better than retinyl esters, in the second microparticulate phase. Using a standard model of topical drug release, the MICROSPQNGE delivery system has been shown to extend the release of hydroquinone. The multi-phasic formulation aIows for the hydroquinone to be sequestered within the two phases which allows for both immediate and gradual release of the active ingredient into the skin.The multi-phasic composition packaged in an airIess pump aIso improves the stabihty of the hydroquinone when compared to other formulations not containing the mictoparticulate, thus preserving the efficacy of the product. Hydroquinone is 1,4-benzenediol.Hydroquinone is structurally related to monobenzone.Hydroquinone occurs as fine white needles.The drug is freely soluble in water and in alcohol and has pK of 9.96.Chemically, hydroquinone is designated as p-dihydroxybenzene; the empirical formula is C6H6O2; the molecular weigh is 110.1 Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3- (3.4-dihydroxyphenyl) alanine (dopa) and suppression of other melanocyte metabolic processes. Exposure to sunlight or ultraviolet light will cause repigmentation of the bleached areas. Pharmacocinetics: It is widely accepted that the absorption of a topicaly applied drug is affected by many factors, including the vehicle, the drug's soIubility, the conditions of the epidermis including the overall pH,disease state, and genetically driven factors such as oiliness of dryness of the epidermis.The rate of absorption can affect the efficacy and tolerability of the formulation. Epiquin Micro is indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration resulting from the use of or contraceptives, pregnancy, hormone replacement therapy, or skin trauma. Epiquin Micro is contraindicated in any patient with a prior history of hypersensitivity of allergic reaction to hydroquinone or any of the other ingredients. The safety of topical hydroquinone use during pregnancy or on chidren (1 2 years and under) has not been established. A CAUTION: Hydroqurone is a depigmenting agent that may produce unwanted cosmetic effects if not used as directed. The physician should be familar with the contents of this insert before prescribing or dispensing this medication.B. Test for skin sensitivity before using Epiquin Micro by applying a small amount to an unbroken patch of skin and check within 24 hours.Minor redness is not a contraindication, but where there is itching. vesicle formation. or excessive inflammatory response. further treatment is not advised. Close patient supervision is recommended. Contact with the eves should be avoided. If no lightening effect is noted after two months of treatment, use of Epiquin Micro should be discontinued. C.Sunscreen use is an essential aspect of hydroquinone therapy, because even minimal sunlight sustains melanocytic activity. To prevent repigmentation during treatment and maintenance therapy. sun exposure on treated skin should be avoided by application of a broad spectrum sunscreen (SPF 15 or greater) of by use of protective clothing. D. Keep this and aI medications out of reach of children. In case of accidental ingestion, contact a physician or a poison control center immediately. E. WARNING: Contains sodium metabisulfite,a sulfite that may cause serious allergic reactions (e.g., hives, itching, wheezing,anaphylaxis, severe asthma attack) in certain suscepllble persons.F. On rare occasions, a gradual blue-black darkening of the skin may occur, in which case, use of Epiquin Micro should be discontinued and a physician contacted immediately. ADVERSE REACTIONS: No systemic reactions have been reported. Occasional cutaneous hypersensitivity (Iocalized contact dermatitis) may occur, in which case the medication should be discontinued and physician notified immediately. There have been no systemic reactions reported from the use of topical hydroquinone. However, treatment should be Iimited to reIatively small areas of the body at one time, since some patients experience a transient skin reddening and a mild sensation that does not preclude treatment. EpiQun Micro should be applied to the affected areas twice daily, morning and before bedtime, or as directed by a physician. Replace cap after each use. To prevent repigmentation during and after the use of Epiquin Micro, sun exposure should be limited and a sunscreen agent or sun-protective clothing should be used to cover the treated areas. There is no recommended dosage for pediatric patients under 12 years of age except under the advice and supervison of a physician. Epiquin Micro is supplied as follows:SIZE: 40 g tube with an airIess pump dispenser NDC NUMBER: 67402-010-40 Store at 25C (77F): excursions permitted to 15C- 30C (59F- 86F) (see USP Controled Room Temperature) Enter section text here A. Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman, or can affect reproductive capacity. It is not known to what degree. if any, topical hydroquinone is absorbed systemically.Topical hydroquinone Should be used in pregnant women only when clearly indicated. B. Nursing mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when hydroquinone is used by a nursing mother. C. Pediatric usage: Safety and effectiveness in pediatric patients below the age of 12 years have not been established. Epiquin Micro hydroquinone cream Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:67402-010 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength hydroquinone (hydroquinone) hydroquinone 4 g in 100 g Inactive Ingredients Ingredient Name Strength ascorbic acid ascorbyl palmitate benzyl alcohol butylated hydroxytoluene LEVOMENOL C10-30 CHOLESTEROL/LANOSTEROL ESTERS C13-14 isoparaffin medium-chain triglycerides cetostearyl alcohol cetyl alcohol cetyl phosphate cyclomethicone 6 CYCLOMETHICONE 5 dimethicone edetate disodium glycerin laureth-7 magnesium aluminum silicate methylparaben PEG-10 soy sterol Phenoxyethanol Polysorbate 20 Polysorbate 60 Propyl gallate Retinol Sodium metabisulfite trolamine stearate .ALPHA.-TOCOPHEROL ACETATE, DL- trolamine water Packaging # Item Code Package Description 1 NDC:67402-010-40 12 CARTON (CARTON) in 1 CASE 1 1 TUBE (TUBE) in 1 CARTON 1 40 g in 1 TUBE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 04/21/2011 Labeler - SkinMedica, Inc. (124977005) Registrant - Harmony Labs, Inc (105803274) Establishment Name Address ID/FEI Operations Harmony Labs, Inc 105803274 pack, label Establishment Name Address ID/FEI Operations AMCOL Health & Beauty Solution, Incorporated 872684803 manufacture Revised: 08/2011 SkinMedica, Inc. Next Pregnancy Warnings Print this page Add to My Med List More about EpiQuin Micro (hydroquinone topical) Side Effects During Pregnancy Dosage Information Support Group En Español 0 Reviews Add your own review/rating Drug class: topical depigmenting agents Consumer resources EpiQuin Micro Professional resources Hydroquinone (AHFS Monograph) Hydroquinone Time Release Cream (FDA) Other brands: Melamin , Lustra , Melquin HP , Skin Lightening Complex , ... +18 more Related treatment guides Dermatological Disorders} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx OTC Availability Rx and/or OTC C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Drug Class Topical depigmenting agents Related Drugs topical depigmenting agents hydroquinone topical , Melamin , Tri-Luma , Lustra Dermatological Disorders triamcinolone , clobetasol topical , betamethasone , Temovate , Diprolene , Analpram-HC , Celestone , urea topical , Clobex , Valisone , Proctofoam HC , hydroquinone topical , sodium hyaluronate topical , Olux , Betamethacot , Diprosone , salicylic acid topical , Diprolene AF , Melamin , Celestone Soluspan , Analpram E , Clobevate , More... EpiQuin Micro Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first!} } the reality
this day Epiquin Micro demanding
EmoticonEmoticon